Noticias

Gold 2023: Highlights for primary care

julio 31, 2023

COPD is a common, preventable, and treatable disease, but extensive under-diagnosis and misdiagnosis leads to patients receiving no treatment or incorrect treatment.

Biologics for COPD — Finally Here

julio 20, 2023

The use of biologic therapies, including monoclonal antibodies, has revolutionized the treatment of many human diseases.

Autoimmunity Day 2023

julio 12, 2023

Senescencia y progresión a daño orgánico en las enfermedades crónicas inmunomediadas: ¿Podemos prevenirlo?

Supranormal lung function: Prevalence, associated factors and clinical manifestations across the lifespan

julio 11, 2023

It is now well established that there are different life-long lung function trajectories in the general population, and that some are associated with better or worse health outcomes.

Àlvar Agustí en la XXXV edición de las Jornadas Técnicas del Institut Guttmann

julio 4, 2023

En la XXXV edición de las Jornadas Técnicas del Institut Guttmann expertos en neurorrehabilitación, en metodología XPA, en humanización y en gestión aportaron conocimientos, ideas y buenas prácticas para humanizar la gestión y la atención sanitaria en las organizaciones asistenciales.

Updated Definition of Chronic Obstructive Pulmonary Disease in the Global Initiative for Chronic Obstructive Lung Disease 2023 Executive Report: Expert Perspectives

junio 29, 2023

In this expert interview, MeiLan K Han and Alvar Agustí discuss the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 executive report, which proposes a new definition for COPD and covers the latest updates in its diagnosis, management, and prevention.

Taking place on 5 July: New concepts in COPD

junio 27, 2023

Taking place on 5 July, this ERS Vision Live panel discussion will focus on new concepts in chronic obstructive pulmonary disease (COPD).

When GETomics meets aging and exercise in COPD

junio 7, 2023

The term GETomics has been recently proposed to illustrate that human health and disease are actually the final outcome of many dynamic, interacting and cumulative gene environment interactions that occur through the lifetime of the individual.

Global Burden of Diseases Study 2017 and Respiratory diseases

Tackling the global burden of lung disease through prevention and early diagnosis

junio 7, 2023

The Global Burden of Disease Study 2017 identified that a country’s sociodemographic index was a key factor affecting mortality and loss of health from respiratory diseases.

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists

mayo 26, 2023

COPD is the elephant in the room for many patients with CVDs.

Gold 2023: Highlights for primary care

Biologics for COPD — Finally Here

Autoimmunity Day 2023

Supranormal lung function: Prevalence, associated factors and clinical manifestations across the lifespan

Àlvar Agustí en la XXXV edición de las Jornadas Técnicas del Institut Guttmann

Updated Definition of Chronic Obstructive Pulmonary Disease in the Global Initiative for Chronic Obstructive Lung Disease 2023 Executive Report: Expert Perspectives

Taking place on 5 July: New concepts in COPD

When GETomics meets aging and exercise in COPD

Tackling the global burden of lung disease through prevention and early diagnosis

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists

Cátedra UB de Salud Respiratoria

Recibe avisos de nuevas publicaciones

Legal

2024 © Cátedra UB de Salud Respiratoria. All rights reserved.

Entérate de
Nuestras Publicaciones

Noticias

Cátedra UB de Salud Respiratoria

Recibe avisos de nuevas publicaciones

Legal

2024 © Cátedra UB de Salud Respiratoria. All rights reserved.

Entérate de Nuestras Publicaciones

Entérate de
Nuestras Publicaciones